PRESS RELEASE published on 07/17/2025 at 09:00, 11 months 5 days ago Oxurion sécurise le financement de l'acquisition d'Axiodis CRO et projette un closing de l'opération au 1eraoût 2025 Oxurion sécurise le financement et acquiert 72% d'Axiodis CRO, renforçant sa position dans la recherche clinique. Projet d'expansion en Europe. Informations sur www.oxurion.com Acquisition Financement Europe Recherche Clinique Oxurion
BRIEF published on 07/17/2025 at 08:35, 11 months 5 days ago Oxurion Sécurise le Financement pour l'Acquisition d'Axiodis CRO Acquisition Biopharmaceutique Données Cliniques Oxurion Axiodis CRO
BRIEF published on 07/17/2025 at 08:35, 11 months 5 days ago Oxurion Secures Financing for Major Acquisition Acquisition Biopharmaceutical Clinical Data Oxurion Europe Hub
BRIEF published on 07/17/2025 at 08:35, 11 months 5 days ago Oxurion obtient un financement pour une acquisition majeure Acquisition Biopharmaceutique Données Cliniques Oxurion Plateforme Européenne
PRESS RELEASE published on 07/17/2025 at 08:30, 11 months 5 days ago Oxurion Secures Financing for the Acquisition of Axiodis CRO and Targets Closing on August 1, 2025 Oxurion NV secures financing for 72% stake in Axiodis CRO, enhancing its clinical data capabilities. Acquisition aligned with strategic roadmap for European hub. Closing set for August 1, 2025 Acquisition Clinical Data Oxurion NV Axiodis CRO European Hub
PRESS RELEASE published on 07/17/2025 at 08:30, 11 months 5 days ago Oxurion verzekert financiering voor de overname van Axiodis CRO en beoogt een closing op 1 augustus 2025 Oxurion sichert Finanzierung für die Übernahme von Axiodis CRO ab und plant Abschluss der Transaktion am 1. August 2025 Übernahme Finanzierung Oxurion Klinische Daten Therapeutische Entwicklung
BRIEF published on 07/15/2025 at 18:05, 11 months 7 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Shares Transparency Atlas Biopharmaceutical Oxurion
BRIEF published on 07/15/2025 at 18:05, 11 months 7 days ago Oxurion reçoit une notification de transparence d'Atlas Special Opportunities II LLC Actions Atlas Transparence Biopharmaceutique Oxurion
PRESS RELEASE published on 07/15/2025 at 18:00, 11 months 7 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV receives transparency notification from Atlas Special Opportunities II, LLC regarding shareholding threshold crossing under Belgian Transparency legislation Transparency Notification Shareholding Oxurion NV Belgian Legislation Atlas Special Opportunities II LLC
PRESS RELEASE published on 07/15/2025 at 18:00, 11 months 7 days ago Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC Oxurion NV meldt ontvangst van transparantiekennisgeving en verlaagd aandelenposities onder wettelijke drempel. Biofarmaceutisch bedrijf in Leuven actief op gebied van therapeutische innovatie en klinisch onderzoek Transparantiekennisgeving Euronext Brussel Oxurion NV Leuven Biofarmaceutisch
Published on 06/23/2026 at 01:55, 3 hours 20 minutes ago Ameriwest Launches Bornite Community and Stakeholder Engagement Program
Published on 06/22/2026 at 23:25, 5 hours 50 minutes ago Infield Minerals Announces Intention to Issue Shares for Kings Canyon Gold Property Option Payment
Published on 06/22/2026 at 23:05, 6 hours 10 minutes ago Gamma Resources Settles Remaining Balance of Outstanding Debt
Published on 06/22/2026 at 21:05, 8 hours 10 minutes ago RUM Announces Voting Results From Annual General Meeting of Shareholders
Published on 06/22/2026 at 19:45, 9 hours 30 minutes ago Trans Canada Gold Appoints Paradigm Drilling Ltd. for Drilling at the Harrison Lake District Scale Gold Project, Drilling to Commence Shortly
Published on 06/23/2026 at 04:05, 1 hour 9 minutes ago Aosom France x FFHandball: Enhancing the Fan Experience Through Home & Outdoor Living Solutions
Published on 06/23/2026 at 01:35, 3 hours 39 minutes ago DoH and Sanofi Partner to Advance Vaccine Innovation
Published on 06/22/2026 at 21:07, 8 hours 7 minutes ago EQS-Adhoc: RWE Aktiengesellschaft: RWE sets placement price for shares from capital measure and raises gross proceeds of 4 billion EUR
Published on 06/22/2026 at 20:50, 8 hours 24 minutes ago Ethlabs, Founded by Former Ethereum Foundation Contributors and Funded by Bitmine, Sharplink and Joe Lubin, Launches to Accelerate Ethereum's Institutional Supercycle
Published on 06/22/2026 at 18:16, 10 hours 58 minutes ago ANTOINE FREY SE RENFORCE AU CAPITAL DE FREY
Published on 06/22/2026 at 18:00, 11 hours 15 minutes ago GUILLEMOT CORPORATION : DECES DE M. CLAUDE GUILLEMOT, Président du Groupe GUILLEMOT CORPORATION